메뉴 건너뛰기
Journal of Clinical Psychopharmacology
Volumn 27, Issue 3, 2007, Pages 302-303
Hypophosphatemia and neuroleptic malignant syndrome [1]
Author keywords

[No Author keywords available]
Indexed keywords

CLOZAPINE; HALOPERIDOL; PHOSPHATE; QUETIAPINE; RISPERIDONE;
EID: 34248529826     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000270094.78027.bf     Document Type: Letter
Times cited : (3)
References (11)
  • 1
    • 0027531002 scopus 로고
    • Neuroleptic malignant syndrome
    • Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77:185-202.
    • (1993) Med Clin North Am , vol.77 , pp. 185-202
    • Caroff, S.N.1    Mann, S.C.2
  • 2
    • 2442436578 scopus 로고    scopus 로고
    • Neuroleptic malignant syndrome and atypical antipsychotic drugs
    • Ananth J, Paramewaran S, Gunatilake S, et al. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatry. 2004;65:464-470.
    • (2004) J Clin Psychiatry , vol.65 , pp. 464-470
    • Ananth, J.1    Paramewaran, S.2    Gunatilake, S.3
  • 3
    • 0025772387 scopus 로고
    • Serum iron and neuroleptic malignant syndrome
    • Rosebush PI, Mazurek MF. Serum iron and neuroleptic malignant syndrome. Lancet. 1991;338:149-151.
    • (1991) Lancet , vol.338 , pp. 149-151
    • Rosebush, P.I.1    Mazurek, M.F.2
  • 4
    • 25444528711 scopus 로고    scopus 로고
    • Hypophosphatemia: An update on its etiology and treatment
    • Gaasbeek A, Meinders AE. Hypophosphatemia: an update on its etiology and treatment. Am J Med. 2005;118:1094-1101.
    • (2005) Am J Med , vol.118 , pp. 1094-1101
    • Gaasbeek, A.1    Meinders, A.E.2
  • 6
    • 27944504372 scopus 로고    scopus 로고
    • Diagnostic uncertainty in a case of neuroleptic malignant syndrome
    • Seitz DP. Diagnostic uncertainty in a case of neuroleptic malignant syndrome. Can J Emerg Med. 2005;266:266-272.
    • (2005) Can J Emerg Med , vol.266 , pp. 266-272
    • Seitz, D.P.1
  • 7
    • 0028806374 scopus 로고
    • Clozapine-induced neuroleptic malignant syndrome: Review and report of new cases
    • Sachdev P, Kruk J, Kneebone M, et al. Clozapine-induced neuroleptic malignant syndrome: review and report of new cases. J Clin Psychopharmacol. 1995;15:365-371.
    • (1995) J Clin Psychopharmacol , vol.15 , pp. 365-371
    • Sachdev, P.1    Kruk, J.2    Kneebone, M.3
  • 8
    • 0023618786 scopus 로고
    • Neuroleptic malignant syndrome: Physiological and laboratory findings in a series of nine cases
    • Harsch HH. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases. J Clin Psychiatry. 1987;48:328-333.
    • (1987) J Clin Psychiatry , vol.48 , pp. 328-333
    • Harsch, H.H.1
  • 9
    • 11344282271 scopus 로고    scopus 로고
    • Neuroleptic malignant syndrome after haloperidol and fentanyl infusion in a patient with cancer with severe mineral imbalance
    • Morita T, Shishido K, Tei Y, et al. Neuroleptic malignant syndrome after haloperidol and fentanyl infusion in a patient with cancer with severe mineral imbalance. J Palliat Med. 2004;7:861-864.
    • (2004) J Palliat Med , vol.7 , pp. 861-864
    • Morita, T.1    Shishido, K.2    Tei, Y.3
  • 10
    • 0024334630 scopus 로고
    • A prospective analysis of 24 episodes of neuroleptic malignant syndrome
    • Rosebush P, Stewart T. A prospective analysis of 24 episodes of neuroleptic malignant syndrome. Am J Psychiatry. 1989;146:717-725.
    • (1989) Am J Psychiatry , vol.146 , pp. 717-725
    • Rosebush, P.1    Stewart, T.2
  • 11
    • 23044520302 scopus 로고    scopus 로고
    • The role of calcium and peripheral catecholamines in the pathophysiology of neuroleptic malignant syndrome
    • Gurrera RJ. The role of calcium and peripheral catecholamines in the pathophysiology of neuroleptic malignant syndrome. Psychiatr Ann. 2000;30:356-362.
    • (2000) Psychiatr Ann , vol.30 , pp. 356-362
    • Gurrera, R.J.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.